Clinical Trial Services Market Size, Share & Trends Analysis Report By Service (Clinical Trial Site Management, Patient Recruitment Management, (Patient recruitment & registry services, Patient retention, Others), Data Management, Administrative staff, IRB, Others), By Phase, (Phase I, Phase II, Phase III, Phase IV), By Sponsor, By Region, Forecasts, 2024-2031

Chapter 1. Methodology and Scope

1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Clinical Trial Services Market Snapshot

Chapter 4. Global Clinical Trial Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Service Outlook Estimates & Trend Analysis
5.1. By Service Outlook & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Service Outlook:

5.2.1. Clinical Trial Site Management
5.2.2. Patient Recruitment Management

5.2.2.1. Patient recruitment & registry services
5.2.2.2. Patient retention
5.2.2.3. Others

5.2.6. Data Management
5.2.7. Administrative staff
5.2.8. IRB
5.2.9. Others

Chapter 6. Market Segmentation 2: By Phase Estimates & Trend Analysis
6.1. By Phase & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Phase:

6.2.1. Phase I
6.2.2. Phase II
6.2.3. Phase III
6.2.4. Phase IV

Chapter 7. Market Segmentation 3: By Sponsor Estimates & Trend Analysis
7.1. By Sponsor & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Sponsor:

7.2.1. Pharmaceutical & Biopharmaceutical
7.2.2. Medical Devices
7.2.3. Others

Chapter 8. Clinical Trial Services Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America
8.1.1. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.1.2. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.1.3. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.1.4. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031

8.2. Europe
8.2.1. Europe Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.2.2. Europe Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.2.3. Europe Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.2.4. Europe Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031

8.3. Asia Pacific
8.3.1. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.3.2. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.3.3. Asia-Pacific Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.3.4. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031

8.4. Latin America
8.4.1. Latin America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.4.2. Latin America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.4.3. Latin America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.4.4. Latin America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031

8.5. Middle East & Africa
8.5.1. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.5.2. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.5.3. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.5.4. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031

Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles

9.2.1. PharmaLex
9.2.2. Emergo UL
9.2.3. Cytel
9.2.4. Health Policy Associate
9.2.5. CD BioSciences
9.2.6. LLX Solutions
9.2.7. SGS
9.2.8. ADM Korea
9.2.9. ClinAsia
9.2.10. BioPoint
9.2.11. Covance, Inc
9.2.12. Charles River Laboratories
9.2.13. Alcura Health
9.2.14. Parexel International
9.2.15. Accovion GmbH
9.2.16. ICON PLC
9.2.17. Chiltern International Limited
9.2.18. inVentiv International Pharma Services
9.2.19. Pharmaceutical Product Development LLC
9.2.20. Pharmnet
9.2.21. IQVIA
9.2.22. Syneos Health
9.2.23. Quotient Bioresearch
9.2.24. WuXi PharmaTech
9.2.25. Other Prominent Players

Global Clinical Trial Services Market Segmentation

Clinical Trial Services Market- By Service 

• Clinical Trial Site Management
• Patient Recruitment Management
  • Patient recruitment & registry services
  • Patient retention
  • Others
• Data Management
• Administrative Staff
• IRB
• Others

Clinical Trial Services Market- Distribution by Phase

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trial Services Market- By Sponsor

• Pharmaceutical & Biopharmaceutical
• Medical Devices
• Others

Global Clinical Trial Services Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Region

• Europe
• U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• North America
  • U.S.
  • Canada
• Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

• Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
• External and internal proprietary databases, regulatory databases, and relevant patent analysis
• Statistical databases, National government documents, and market reports
• Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

• Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
• Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
• Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
• End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.